Bayer

Bayer halts sales of Essure outside US
Bayer halts sales of Essure outside US
Mass Device
Bayer
Essure
contraceptives
devices
Flag link:
Bayer gears up to take on Gilead in lymphoma with Aliqopa green light
Bayer gears up to take on Gilead in lymphoma with Aliqopa green light
Fierce Pharma
Bayer
Gilead Sciences
Aliqopa
copanlisib
relapsed follicular lymphoma
Flag link:
Bayer boosted as FDA OKs its PI3K drug Aliqopa for relapsed follicular lymphoma patients
Bayer boosted as FDA OKs its PI3K drug Aliqopa for relapsed follicular lymphoma patients
Endpoints
Bayer
FDA
Aliqopa
relapsed follicular lymphoma
Flag link:
Hemo-oncology newbie Bayer gears up for copanlisib launch
Hemo-oncology newbie Bayer gears up for copanlisib launch
Fierce Pharma
hemo-oncology
Bayer
drug launches
copanlisib
lymphoma
Flag link:
Bayer files longer-acting bleeding candidate to FDA
Bayer files longer-acting bleeding candidate to FDA
Fierce Biotech
Bayer
FDA
BAY94-9027
hemophilia A
Flag link:
ESC 2017 – Bleeding blunts Xarelto’s Compass victory
ESC 2017 – Bleeding blunts Xarelto’s Compass victory
EP Vantage
European Society of Cardiology
Xarelto
bloodthinners
Bayer
J&J
Flag link:
Pharma Stocks That Could Move On New Data
Pharma Stocks That Could Move On New Data
Barron's
pharma stocks
AbbVie
Bayer
Novartis
Bristol-Myers Squibb
Eli Lilly
European Society of Cardiology
Flag link:
Bayer, J&J win third U.S. trial over Xarelto bleeding risk
Bayer, J&J win third U.S. trial over Xarelto bleeding risk
Yahoo/Reuters
Bayer
JNJ
Xarelto
bloodthinners
Flag link:
Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers
Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers
Fierce Pharma
multiple sclerosis
MS
drug pricing
Bayer
Biogen
Merck KGaA
Novartis
Sanofi
Teva Pharmaceutical
Roche
Flag link:
The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results
The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results
Fierce Pharma
pharma stocks
Merck
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
GSK
Roche
Sanofi
Bayer
Novo Nordisk
Celgene
Biogen
AstraZeneca
Flag link:
Bayer drops checkpoint regulator from Compugen pact
Bayer drops checkpoint regulator from Compugen pact
Fierce Biotech
Bayer
CompuGen
CGEN-15022
immune checkpoint regulators
Flag link:
Why ImmunoGen, Inc. Jumped Higher Today
Why ImmunoGen, Inc. Jumped Higher Today
Motley Fool
Immunogen
anetumab ravtansine
Bayer
mesothelioma
Flag link:
Bayer misses in mesothelioma Phase 2
Bayer misses in mesothelioma Phase 2
BioPharma Dive
Bayer
mesothelioma
clinical trials
anetumab ravtansine
Flag link:
Bayer’s blockbuster pipeline promises broken by a PhII setback for top cancer drug
Bayer’s blockbuster pipeline promises broken by a PhII setback for top cancer drug
Endpoints
Bayer
clinical trials
anetumab ravtansine
mesothelioma
Flag link:
Missouri judge slashes 86 plaintiffs from Essure suit against Bayer
Missouri judge slashes 86 plaintiffs from Essure suit against Bayer
Mass Device
Missouri
Essure
Bayer
devices
contraceptives
Flag link:
More consumer woes for Bayer drag down sales, earnings forecasts
More consumer woes for Bayer drag down sales, earnings forecasts
Fierce Pharma
Bayer
earnings
Flag link:
Johnson & Johnson, Bayer score a second key win in Xarelto bleeding litigation
Johnson & Johnson, Bayer score a second key win in Xarelto bleeding litigation
Fierce Pharma
JNJ
Bayer
Xarelto
bloodthinners
Flag link:
Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar
Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar
Fierce Pharma
Eisai
Lenvima
liver cancer
Bayer
Nexavar
ASCO 2017
Flag link:
Bayer cancer drug boards path to speedy approval at FDA
Bayer cancer drug boards path to speedy approval at FDA
Fierce Biotech
Bayer
FDA
copanlisib
priority review
non-Hodgkin's lymphoma
Flag link:
J&J, Bayer prevail in bellwether Xarelto trial
J&J, Bayer prevail in bellwether Xarelto trial
Fierce Pharma
JNJ
Bayer
Xarelto
bloodthinners
Flag link: